中國平安(02318.HK)與創業慧康將共建大醫療健康新生態
中國平安(02318.HK)旗下平安醫保科技、平安創投、平安智慧城市與上市公司創業慧康(300451.SZ)聯合宣布,未來將充分發揮各自領域優勢,共同探索智慧醫保、智慧醫療、智慧商保等應用場景方面的戰略合作,通過科技驅動與數據賦能,全方位打造醫療健康新生態體系。
平安醫保科技副總經理兼CTO楊偉棟介紹了《平安醫保科技與創業慧康總體合作框架》。平安醫保科技將圍繞衛生健康保險信息化建設,基於互惠共贏、優勢互補的原則,在政府、醫療、互聯網、健康服務運營等方面,與創業慧康開展形式多樣的深度合作,共同推動醫保平台的建設及健康服務的普惠,助力中國醫保發展的新一輪升級。
創業慧康董事長葛航表示,平安和創業慧康在「健康中國」的發展方向指導下,實現在醫院信息化建設及人工智能、醫療服務等方面的緊密合作,將是創業慧康發展的新一輪里程碑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.